van Rooij Sanne J H, Geuze Elbert, Kennis Mitzy, Rademaker Arthur R, Vink Matthijs
1] Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands [2] Research Centre Military Mental Healthcare, Ministry of Defence, Utrecht, The Netherlands.
Research Centre Military Mental Healthcare, Ministry of Defence, Utrecht, The Netherlands.
Neuropsychopharmacology. 2015 Feb;40(3):667-75. doi: 10.1038/npp.2014.220. Epub 2014 Aug 26.
Thirty to fifty percent of posttraumatic stress disorder (PTSD) patients do not respond to treatment. Understanding the neural mechanisms underlying treatment response could contribute to improve response rates. PTSD is often associated with decreased inhibition of fear responses in a safe environment. Importantly, the mechanism of effective treatment (psychotherapy) relies on inhibition and so-called contextual cue processing. Therefore, we investigate inhibition and contextual cue processing in the context of treatment. Forty-one male war veterans with PTSD and 22 healthy male war veterans (combat controls) were scanned twice with a 6- to 8-month interval, in which PTSD patients received treatment (psychotherapy). We distinguished treatment responders from nonresponders on the base of percentage symptom decrease. Inhibition and contextual cue processing were assessed with the stop-signal anticipation task. Behavioral and functional MRI measures were compared between PTSD patients and combat controls, and between responders and nonresponders using repeated measures analyses. PTSD patients showed behavioral and neural deficits in inhibition and contextual cue processing at both time points compared with combat controls. These deficits were unaffected by treatment; therefore, they likely represent vulnerability factors or scar aspects of PTSD. Second, responders showed increased pretreatment activation of the left inferior parietal lobe (IPL) during contextual cue processing compared with nonresponders. Moreover, left IPL activation predicted percentage symptom improvement. The IPL has an important role in contextual cue processing, and may therefore facilitate the effect of psychotherapy. Hence, increased left IPL activation may represent a potential predictive biomarker for PTSD treatment response.
30%至50%的创伤后应激障碍(PTSD)患者对治疗无反应。了解治疗反应背后的神经机制有助于提高反应率。PTSD通常与在安全环境中恐惧反应抑制能力下降有关。重要的是,有效治疗(心理治疗)的机制依赖于抑制作用以及所谓的情境线索处理。因此,我们在治疗背景下研究抑制作用和情境线索处理。41名患有PTSD的男性退伍军人和22名健康男性退伍军人(战斗对照)在6至8个月的间隔内接受了两次扫描,在此期间PTSD患者接受了治疗(心理治疗)。我们根据症状减轻的百分比区分治疗反应者和无反应者。使用停止信号预期任务评估抑制作用和情境线索处理。使用重复测量分析比较PTSD患者与战斗对照之间以及反应者与无反应者之间的行为和功能磁共振成像测量结果。与战斗对照相比,PTSD患者在两个时间点的抑制作用和情境线索处理方面均表现出行为和神经缺陷。这些缺陷不受治疗影响;因此,它们可能代表PTSD的易感性因素或瘢痕方面。其次,与无反应者相比,反应者在情境线索处理期间左顶下叶(IPL)的预处理激活增加。此外,左IPL激活预测症状改善的百分比。IPL在情境线索处理中起重要作用,因此可能促进心理治疗的效果。因此,左IPL激活增加可能代表PTSD治疗反应的潜在预测生物标志物。